tradmap

CELU Earnings Celularity Inc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$11 -$5 $1 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $27M $54M 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$208M -$97M $14M $0 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$12 -$6 $0 Q1 '22 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25
EPS
Revenue (quarterly)
$0 $9M $18M Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25
Revenue
Net income (quarterly)
-$94M -$42M $10M $0 Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25
Net income

Reported EPS history

1–20 of 20
FY 20252025-12-31-3.592026-04-3010-K
Q3 20252025-09-30-2.742025-11-1410-Q
Q2 20252025-06-30-1.862025-08-2910-Q
Q1 20252025-03-31-0.842025-08-2910-Q
FY 20252024-12-31-2.642026-04-3010-K
Q3 20252024-09-30-2.052025-11-1410-Q
Q2 20252024-06-30-1.322025-08-2910-Q
Q1 20252024-03-31-1.032025-08-2910-Q
FY 20242023-12-31-11.022025-05-0810-K
Q3 20242023-09-30-11.862024-12-0610-Q
Q2 20242023-06-30-6.742024-11-0710-Q
Q1 20242023-03-31-4.122024-10-1610-Q
FY 20232022-12-310.952024-07-3010-K
Q3 20232022-09-30-0.072024-01-0310-Q
Q2 20232022-06-30-0.112023-08-1410-Q
Q1 20232022-03-31-0.482023-05-2210-Q
FY 20222021-12-31-1.492023-03-3110-K
Q3 20222021-09-30-2.002022-11-1010-Q
Q2 20222021-06-30-6.092022-08-0910-Q
Q3 20212020-09-30-11.522021-11-1210-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.